missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CDKN2AIP (aa 504-573) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (99%), Rat (99%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59549 (PA5-59549. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
CARF was first cloned as a novel binding partner of ARF from a yeast-interactive screen. CARF and ARF colocalize in the perinucleolar region and have a collaborative function. In the nucleoplasm, CARF interacts with p53 and enhances its function. The p53 downregulates CARF in a negative feedback regulatory loop and may also involve p53 antagonist HDM2.
Specifications
Specifications
| Accession Number | Q9NXV6 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 55602 |
| Name | Human CDKN2AIP (aa 504-573) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 4921511I16Rik; AW208986; CARF; CDKN2A interacting protein; CDKN2A-interacting protein; CDKN2A-interacting protein-like protein; Cdkn2aip; CDKN2AIP-like protein; collaborates/cooperates with ARF (alternate reading frame) protein; collaborator of ARF; MGC137334 protein; RGD1305302 |
| Common Name | CDKN2AIP |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction